UCLA Health: FDA Approves Gene Therapy for Severe Leukocyte Adhesion Deficiency-I, A Rare Immune Disorder
March 27, 2026
March 27, 2026
LOS ANGELES, California, March 27 (TNSjou) -- The UCLA Health issued the following news release:
* * *
FDA approves gene therapy for severe leukocyte adhesion deficiency-I, a rare immune disorder
All children treated in a clinical trial are living with restored immune function
*
Dr. Donald Kohn has been developing gene therapies for rare pediatric immune disorders for over 30 years. This week, his role in a clinical trial has culmi . . .
* * *
FDA approves gene therapy for severe leukocyte adhesion deficiency-I, a rare immune disorder
All children treated in a clinical trial are living with restored immune function
*
Dr. Donald Kohn has been developing gene therapies for rare pediatric immune disorders for over 30 years. This week, his role in a clinical trial has culmi . . .